Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.740
-0.390 (-7.60%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $278.3 million as of July 30, 2026. Its market cap has decreased by -23.19% in one year.
Market Cap
278.30M
Enterprise Value
136.67M
1-Year Change
-23.19%
Ranking
Category
Stock Price
$4.74
ChartMarket Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $278.30M, a decrease of -50.78%. That is a compound annual growth rate of -11.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 278.30M | -8.87% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 328.88M |
| Vicore Pharma Holding AB | 321.73M |
| Lyell Immunopharma | 318.31M |
| Neumora Therapeutics | 311.28M |
| Vanda Pharmaceuticals | 310.30M |
| Agenus | 295.37M |
| OmniAb | 285.60M |
| Opus Genetics | 281.55M |